| Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label … HA Tawbi, PA Forsyth, FS Hodi, AP Algazi, O Hamid, CD Lao, ... The lancet oncology 22 (12), 1692-1704, 2021 | 267 | 2021 |
| Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells S Lawn, N Krishna, A Pisklakova, X Qu, DA Fenstermacher, M Fournier, ... Journal of Biological Chemistry 290 (6), 3814-3824, 2015 | 155 | 2015 |
| The use of magnetic resonance imaging to noninvasively detect genetic signatures in oligodendroglioma R Brown, M Zlatescu, A Sijben, G Roldan, J Easaw, P Forsyth, I Parney, ... Clinical Cancer Research 14 (8), 2357-2362, 2008 | 152 | 2008 |
| Single-cell characterization of the immune microenvironment of melanoma brain and leptomeningeal metastases I Smalley, Z Chen, M Phadke, J Li, X Yu, C Wyatt, B Evernden, JL Messina, ... Clinical Cancer Research 27 (14), 4109-4125, 2021 | 110 | 2021 |
| Management of brain metastases in breast cancer: a review of current practices and emerging treatments MN Mills, NB Figura, JA Arrington, HHM Yu, AB Etame, MA Vogelbaum, ... Breast cancer research and treatment 180, 279-300, 2020 | 82 | 2020 |
| A Prospective Validation Study of the First 3D Digital Exoscope for Visualization of 5-ALA–Induced Fluorescence in High-Grade Gliomas MA Vogelbaum, D Kroll, A Etame, N Tran, J Liu, A Ford, E Sparr, Y Kim, ... World neurosurgery 149, e498-e503, 2021 | 22 | 2021 |
| Targeted therapy given after anti–PD-1 leads to prolonged responses in mouse melanoma models through sustained antitumor immunity MS Phadke, Z Chen, J Li, E Mohamed, MA Davies, I Smalley, DR Duckett, ... Cancer immunology research 9 (5), 554-567, 2021 | 20 | 2021 |
| A randomized wait-list controlled trial of a social support intervention for caregivers of patients with primary malignant brain tumor M Reblin, D Ketcher, R McCormick, V Barrios-Monroy, SK Sutton, ... BMC health services research 21, 1-8, 2021 | 16 | 2021 |
| Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4+ Th1 Responses and Potential Use as a Cancer Vaccine A Basu, GK Albert, S Awshah, J Datta, KN Kodumudi, C Gallen, A Beyer, ... Cancer immunology research 10 (1), 108-125, 2022 | 14 | 2022 |
| A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma V Law, Z Chen, F Vena, I Smalley, R Macaulay, BR Evernden, N Tran, ... Neuro-oncology 24 (10), 1673-1686, 2022 | 12 | 2022 |
| Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease MN Mills, W King, A Soyano, Y Pina, BJ Czerniecki, PA Forsyth, ... Journal of Neuro-Oncology 157 (2), 249-269, 2022 | 11 | 2022 |
| HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasis MF Emmons, RL Bennett, A Riva, K Gupta, LADC Carvalho, C Zhang, ... Nature communications 14 (1), 7759, 2023 | 10 | 2023 |
| Leptomeningeal disease (LMD) in patients with melanoma metastases ML Khaled, AA Tarhini, PA Forsyth, I Smalley, Y Piña Cancers 15 (6), 1884, 2023 | 10 | 2023 |
| Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: a nonrandomized, open-label phase 1b study KA Ahmed, Y Kim, JA Arrington, S Kim, M DeJesus, AE Soyano, ... Advances in Radiation Oncology 6 (6), 100798, 2021 | 10 | 2021 |
| A rare case of leptomeningeal carcinomatosis in a patient with uveal melanoma: case report and review of literature IV Fedorenko, B Evernden, RS Kenchappa, S Sahebjam, E Ryzhova, ... Melanoma research 26 (5), 481-486, 2016 | 10 | 2016 |
| Addressing a critical need for caregiver support in neuro-oncology: development of a caregiver navigation intervention using eSNAP social resource visualization M Reblin, KJ Wells, A Otto, R McCormick, L Rodriguez, K Walters, ... Supportive Care in Cancer 30 (6), 5361-5370, 2022 | 9 | 2022 |
| Clinical outcomes of non–small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors … AE Dohm, JD Tang, MN Mills, CL Liveringhouse, ML Sandoval, BA Perez, ... Journal of Neurosurgery 138 (6), 1600-1607, 2022 | 8 | 2022 |
| The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs MN Mills, TK Potluri, Y Kawahara, M Fahey, NB Figura, AE Soyano, ... Breast Cancer Research and Treatment, 1-9, 2022 | 8 | 2022 |
| Advances in diagnosis and treatment for leptomeningeal disease in melanoma Y Piña, S Yadugiri, DN Yeboa, SD Ferguson, PA Forsyth, ICG Oliva Current oncology reports 24 (1), 43-54, 2022 | 7 | 2022 |
| Stereotactic radiosurgery and anti-PD-1+ CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the … AE Dohm, JY Nakashima, H Kalagotla, SX Jiang, JD Tang, M Bhandari, ... European Journal of Cancer 192, 113287, 2023 | 6 | 2023 |